Internal jugular vein thrombosis presenting as a painful neck mass due to a spontaneous dislocated subclavian port catheter as long-term complication: a case report by Binnebösel, Marcel et al.
Case report
Open Access
Internal jugular vein thrombosis presenting as a painful neck mass
due to a spontaneous dislocated subclavian port catheter
as long-term complication: a case report
Marcel Binnebösel*, Jochen Grommes, Karsten Junge, Sonja Göbner,
Volker Schumpelick and Son Truong
Address: Department of Surgery, RWTH Aachen University Hospital, Germany
Email: MB* - mbinneboesel@ukaachen.de; JG - jgrommes@ukaachen.de; KJ - kjunge@ukaachen.de; SG - sgoebner@ukaachen.de;
VS - vschumpelick@ukaachen.de; ST - struong@ukaachen.de
*Corresponding author
Received: 4 November 2008 Accepted: 20 April 2009 Published: 9 June 2009
Cases Journal 2009, 2:7991 doi: 10.4076/1757-1626-2-7991
This article is available from: http://casesjournal.com/casesjournal/article/view/7991
© 2009 Binnebösel et al; licensee Cases Network Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0),
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Abstract
Central venous access devices are extensively used for long-term chemotherapy and parenteral
nutrition. However, there are some possible immediate, early, and late complications related to
the implantation technique, care, and maintenance. We present the uncommon occurrence of a
thrombosis of the internal jugular vein due to a spontaneous migration of a Port-A-Cath catheter into
the ipsilateral internal jugular vein as a delayed complication of a central venous access catheter
implanted for chemotherapy delivery. A review of the literature is given, and the factors responsible
for this unusual complication will be discussed.
Introduction
Central venous access devices are extensively used for long-
term chemotherapy and parenteral nutrition. They have
several advantages compared to other methods of venous
access: they are easy to implant under local anaesthesia,
have less discomfort for the patients, allow low costs, can
be implanted in day cases, and can be managed
ambulatory. However, there are some possible immediate,
early, and late complications related to the implantation
technique, care, and maintenance. Spontaneous migration
as a late complication of central venous catheters after
satisfactory initial placement is uncommon but is asso-
ciated with a number of complications, including neck
pain, shoulder pain, ear pain, infection, venous
thrombosis, and neurological complications. We present
the uncommon occurrence of a thrombosis of the internal
jugular vein due to a spontaneous migration of a Port-A-
Cath catheter into the ipsilateral internal jugular vein as a
delayed complication of a central venous access catheter
implanted for chemotherapy delivery. A review of the
literature is given, and the factors responsible for this
unusual complication will be discussed.
Case presentation
In a 44-year-old female Caucasian patient, adenocarci-
noma of the oesophagus located in the gastro-oesophageal
junction (33 to 39 cm) was diagnosed in August 2007. The
disease was Stage III (T3 N1) because of adventitial
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and paraoesophageal lymph nodes. The patient under-
went preoperative (neoadjuvant) chemotherapy using
ECF (intravenous epirubicin 50 mg/m
2 and cisplatin
60 mg/m
2 every 3 weeks at day one respectively, with
continuous infusion of 5-FU 200 mg/m
2 per day). Three
cycles of the intravenous chemotherapy were administered
after implantation of a central venous access (Figures 1, 2).
The tip of the catheter was advanced to the distal part of
the superior vena cava (SVC) from the left subclavian vein
that was approached by percutaneous implantation using
Seldinger technique in local anaesthesia. Following sub-
cutaneous tunnelling the infusion port was embedded in
front of the left pectoral muscle fascia.
Three month following the beginning of the neoadjuvant
chemotherapy the patient proceeded to surgery. A proximal
gastric resection and transhiatal subtotal oesophagectomy
without thoracotomy through median laparotomy and
left sided cervical incision was performed. Proximal gastric
resection, oesophageal resection and reconstruction were
performedinasingleoperation.Theoesophagealsubstitute
was positioned intheposterior mediastinum inthe original
oesophageal bed (gastric pull-up). Following the gastric
pull-up a feeding nasogastric tube was positioned in the
substitute and bilateral chest drains were performed. The
patient was monitored up to the third postoperative day on
the intensive care unit. All drains were gradually removed
until the seventh postoperative day. The postoperative
course was uneventful, except for a cervical wound healing
complication due to a slight leakage of the gastro-
oesophageal anastomosis. Temporarily feeding was con-
ducted by nasogastrictube,and the leakage was successively
occluded by fibrin sealant via endoscopy. The patient was
hospitalised up to the 28
th postoperative day. One month
following the operation endoscopy confirmed a healed
cervical anastomosis. Therefore, the postoperative che-
motherapy using ECF was resumed two month after the
operation. Because of persistent vomiting and progressive
loss of weight the intravenous chemotherapy was termi-
nated after 2 cycles. Three and six months after termination
of the oncological treatment, radiologically no recurrence
was observed. Endoscopy did also not find any residual
disease, anastomotic stenosis or signs of wound healing
complications.
Eleven month after termination of the oncological
treatment the patient was admitted to our outpatient
clinic because of a left sided painful neck mass. The
C-reactive protein was elevated up to 155 mg/l (reference
range < 5), all other laboratory markers revealed no
pathological results. An ultrasonic testing was performed
and revealed a thrombosis of the left internal jugular vein
due to a bar-shaped intravascular foreign body. Therefore,
a computer tomography of the neck and upper thorax was
arranged (Figure 3). CT scan confirmed thrombosis and
demonstrated an extension of the thrombus up to the left
subclavian vein, which showed proper perfusion. The bar-
shaped intravascular foreign body could be revealed as
ipsilateral dislocated Port-A-Cath catheter in continuity,
whereas a catheter rupture could be excepted. Following
preparation of the patient the Port-a-Cath catheter
was removed surgically. Preoperatively a bolus of
5000 I.U. of an unfractionated heparin was administered
Figure 1. Radiograph of the chest following implantation of
the Port-A-Cath catheter. The tip of the catheter was
advanced to the distal part of the superior vena cava from the
left subclavian vein (white arrows).
Figure 2. Staging CT-scan preoperatively demonstrating an
accurate positioning of the catheter.
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nated heparin per day were administered continuously
intravenously. From the first postoperative day up to the
third postoperative month the anticoagulation was
performed orally (Phenprocoumon). The hospitalisation
was terminated at the third postoperative day.
Discussion
Utilizing Porth-A-Cath catheters in clinical practice
immediate or early complications as well as delayed
complications are known. Immediate or early complica-
tions are frequently related to clinical conditions of the
neoplastic patients, such as necrosis of the skin at the port
side, infection of subcutaneous pocket, and infections of
the port system. In the reviewed literature vascular catheter
infections and catheter thrombosis are the two most
common and serious complications, reported in 0-7.7 and
1.5-13%, respectively [1]. Central venous catheter primary
displacement as early complication is not an uncommon
event and can occur during catheter insertion. The catheter
tip, usually advanced as far as the vena cava-right atrial
junction,canshifttoanothervenousdistrict.Theincidence
ofsuchadisplacementdependsontheapproach.Incaseof
a subclavicular approach, like it was performed in our
patient, the rate of catheter primary displacement is stated
30%fortheexternal jugularvein, and5.7%for theinternal
jugular vein [2,3]. In our case an immediate or early
dislocation can be excepted, because both following
implantation of the catheter and in the CT-scan before
the operation the correct position of the catheter tip could
be confirmed.
Furthermore, delayed complications of Port-A-Cath
catheter are known. Catheter disconnection and emboli-
zation is a rare long-term complication reported in 0.9-
1.7% [4]. Spontaneous intravascular fracture of the outlet
catheter is reported in the literature in 0.6-8% of the cases
[4]. The catheter rupture is often due to the wear over the
costoclavicular angle. Beside an immediate migration of
the catheter from its initial postoperative position, it can
occur several days or month after insertion. In the
reviewed literature the incidence is reported in 2.5-2.6%
of the [1,5].
The proper spontaneous migration mechanism is still
unknown. In the reviewed literature several hypotheses
are given, such as forced flushing, upper extremity vigorous
movements, neck flexion, congestive heart failure, changing
in thoracic pressure with coughing and vomiting [1,6-8].
Quick thoracic pressure increasing during coughing or
vomiting could cause a temporary venous flux inversion
and determine displacement of the catheter tip. In our
patient a persistent episode of vomiting was existent, and as
such the main cause of premature abruption of ECF
intravenouschemotherapy.We speculate that the migration
in our patient was related to severe vomiting, and thus
vigorous changes of intrathoracic pressure.
Furthermore, in our patient laboratory signs of infection
(elevated C-reactive protein) and thrombosis of the
internal jugular vein was detected. On the one hand vein
thrombosis is not always associated with catheter occlu-
sion and can be asymptomatic [4]. On the other hand a
removal of the catheter in case of deep vein thrombosis is
recommended. To prevent thrombosis which is often
associated with malignant disease, Bern et al. proposed a
prophylactic treatment with 1 mg daily of warfarin in such
patients [9]. The management of catheter-infection has
been controversially discussed during the last decade.
Initially, patients were treated with appropriate antibiotics
and removal of the catheter, However, it is reported in the
literature that patients can safely be treated with appro-
priate antibiotics alone without catheter removal [4,10]. In
any case, the central venous catheter must be removed due
to haemodynamic alterations of the patient or if a specific
antibiotic therapy is not effective [11,12]. To prevent
further complications an early explantation of a central
venous access catheter should be discussed.
In conclusion because catheter migration might be asymp-
tomatic, regular monitoring of the catheter position should
be recommended. By any means prior to a new course of
chemotherapy or encountering symptoms of migration,
obtaining chest radiography is essential to provide early
detection and to avoid consecutive complications. To
prevent further complications an early explantation of a
central venous access catheter should be suggested.
Figure 3. CT-scan representing thrombosis of the left
internal jugular vein due to a dislocated left subclavian catheter
(white arrows).
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